4//SEC Filing
Nivalis Therapeutics, Inc. 4
Accession 0001104659-15-051897
CIK 0001626199operating
Filed
Jul 19, 8:00 PM ET
Accepted
Jul 20, 3:47 PM ET
Size
5.5 KB
Accession
0001104659-15-051897
Insider Transaction Report
Form 4
Furst Howard P.
Director
Transactions
- Award
Stock Option (Right to Buy)
2015-07-16+11,475→ 11,475 totalExercise: $17.49Exp: 2025-07-16→ Common Stock (11,475 underlying)
Footnotes (3)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]The shares shall vest in 36 equal monthly installments measured commencing from June 17, 2015.
- [F3]Inapplicable.
Documents
Issuer
Nivalis Therapeutics, Inc.
CIK 0001626199
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001626199
Filing Metadata
- Form type
- 4
- Filed
- Jul 19, 8:00 PM ET
- Accepted
- Jul 20, 3:47 PM ET
- Size
- 5.5 KB